WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTS.
Giovanni Faria SilvaVanessa Gutierrez de AndradeAlecsandro MoreiraPublished in: Arquivos de gastroenterologia (2019)
We conclude that, patients with advanced cirrhosis should be prioritized for treatment with direct antiviral agents.